贝哲斯咨询统计疟疾药物市场数据显示，2025年全球疟疾药物市场规模达76.42亿元（人民币），2025年中国疟疾药物市场规模达25.29亿元。报告预估到2032年全球疟疾药物市场规模将达到118.34亿元，年复合增长率预计为6.45%。

Mylan Pharmaceuticals Inc. will have to face antitrust claims that it conspired with other drugmakers to inflate generic drug ...

NEW YORK, Feb 1 (Reuters) - Mylan Laboratories Inc. said on Thursday that quarterly profit more than doubled, and reported better-than-expected sales, helped by its generic version of the Ditropan XL ...

NEW YORK (Reuters) - Mylan Laboratories Inc. said on Thursday that quarterly profit more than doubled, helped by sales of its generic version of the Ditropan XL overactive bladder drug and fentanyl ...

PITTSBURGH (AP) -- One of the world's largest generic drug makers, Mylan Laboratories Inc., will buy King Pharmaceuticals Inc. for $4 billion in stock as Mylan makes a stronger foray into the branded ...

A pharmaceutical company has agreed in principle to pay hundreds of millions of dollars which officials say will help combat the opioid crisis across the nation. Under the tentative settlement, Mylan ...

NEW YORK (CBS.MW) -- Mylan Laboratories said the U.S. Food and Drug Administration has approved its Benazepril Hydrochloride Tablets which are used to treat high blood pressure. Four dosages of the ...

SAN FRANCISCO (MarketWatch) -- Mylan Laboratories Inc. myl said Friday its alprazolam extended-release tablets have been approved by the Food and Drug Administration. They are the generic equivalent ...

Financier Carl Icahn and his High River LP affiliate said Wednesday they are again proposing to acquire generic drug maker Mylan Laboratories Inc. for $20 a share, or more than $5 billion.

In Janssen Pharmaceuticals, Inc. v. Mylan Laboratories., the United States Court of Appeals for the Federal Circuit affirmed a district court ruling that a pharmaceutical dosing claim limitation was ...

After five years under Napa County ownership, the multi-million-dollar, 25-acre South Campus still shows a few signs of its former life as a Dey-Mylan pharmaceutical manufacturing and research plant.